Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Sibia Neurosciences licenses transcription-based assay technology to AHP

July 8, 1999

Nexell's stem cell selection systems approved for U.S. marketing

July 7, 1999

Biovation and Tanox enter agreement for antiinflammatory product development

July 7, 1999

Selective Genetics' GAM technology enhances delivery and retention of NTF gene therapy

July 6, 1999

Cambridge Combinatorial to provide chemistry services to Pfizer

July 5, 1999

Lexicon Genetics reports on new drug discovery technology

July 2, 1999

Targeted Genetics obtains exclusive rights to AAV manufacturing patent

July 2, 1999

Potent murine CCR2 receptor antagonist presented at World Congress on Inflammation

July 1, 1999

Gene sequences related to X-linked inhibitor of apoptosis protein discovered

July 1, 1999

Lundbeck develops radiolabeled 5-HT2 receptor antagonist for PET studies

June 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...